Literature DB >> 29226481

No major differences in outcomes between the initial and relapse episodes in patients with thrombotic thrombocytopenic purpura: The experience from the Ohio State University Registry.

Camila Masias1, Haiwa Wu2, Michael McGookey2, Lauren Jay2, Spero Cataland1, Shangbin Yang2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29226481     DOI： 10.1002/ajh.25002

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  3 in total

Review 1.  Clinical and laboratory diagnosis of TTP: an integrated approach.

Authors:  Thita Chiasakul; Adam Cuker
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  ISTH guidelines for treatment of thrombotic thrombocytopenic purpura.

Authors:  X Long Zheng; Sara K Vesely; Spero R Cataland; Paul Coppo; Brian Geldziler; Alfonso Iorio; Masanori Matsumoto; Reem A Mustafa; Menaka Pai; Gail Rock; Lene Russell; Rawan Tarawneh; Julie Valdes; Flora Peyvandi
Journal:  J Thromb Haemost       Date:  2020-09-11       Impact factor: 5.824

3.  Clinical factors and biomarkers predict outcome in patients with immune-mediated thrombotic thrombocytopenic purpura.

Authors:  Elizabeth M Staley; Wenjing Cao; Huy P Pham; Chong H Kim; Nicole K Kocher; Lucy Zheng; Radhika Gangaraju; Robin G Lorenz; Lance A Williams; Marisa B Marques; X Long Zheng
Journal:  Haematologica       Date:  2018-08-31       Impact factor: 9.941
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.